Somewhat Positive Press Coverage Somewhat Unlikely to Affect HealthStream (HSTM) Share Price

Media headlines about HealthStream (NASDAQ:HSTM) have trended somewhat positive this week, Accern reports. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. HealthStream earned a news impact score of 0.14 on Accern’s scale. Accern also assigned headlines about the technology company an impact score of 46.7699632471822 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Several equities analysts have recently issued reports on HSTM shares. ValuEngine cut shares of HealthStream from a “hold” rating to a “sell” rating in a research note on Friday, September 1st. Robert W. Baird dropped their target price on shares of HealthStream from $30.00 to $28.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 25th. Zacks Investment Research raised shares of HealthStream from a “hold” rating to a “strong-buy” rating and set a $27.00 target price on the stock in a research report on Wednesday, October 25th. Canaccord Genuity reissued a “hold” rating and issued a $25.00 target price on shares of HealthStream in a research report on Monday, October 23rd. Finally, Needham & Company LLC downgraded shares of HealthStream from a “buy” rating to a “hold” rating in a research report on Wednesday, October 25th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $24.83.

HealthStream (HSTM) opened at $22.97 on Monday. The firm has a market cap of $732.65, a P/E ratio of 104.41, a PEG ratio of 6.05 and a beta of 0.90. HealthStream has a 1 year low of $20.60 and a 1 year high of $31.53.

HealthStream (NASDAQ:HSTM) last announced its quarterly earnings data on Monday, October 23rd. The technology company reported $0.08 EPS for the quarter, beating the Zacks’ consensus estimate of $0.05 by $0.03. HealthStream had a net margin of 2.36% and a return on equity of 2.46%. The firm had revenue of $63.60 million for the quarter, compared to the consensus estimate of $62.48 million. During the same period in the previous year, the firm posted $0.04 earnings per share. The firm’s revenue was up 8.9% on a year-over-year basis. sell-side analysts anticipate that HealthStream will post 0.23 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive Press Coverage Somewhat Unlikely to Affect HealthStream (HSTM) Share Price” was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.com-unik.info/2017/12/18/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-healthstream-hstm-share-price.html.

HealthStream Company Profile

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Insider Buying and Selling by Quarter for HealthStream (NASDAQ:HSTM)

What are top analysts saying about HealthStream? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthStream and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit